Sign in
CompletedPhase 3

Vitamin D Supplementation in Individuals With a Chronic Spinal Cord Injury

Key facts

Who runs it
Swiss Paraplegic Research, Nottwil
Where
Switzerland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
50 people enrolled
Started
19 May 2021
Ended
23 Jan 2024
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Cholecalciferol (Vitamin D3)
  • Placebo
Record updated
8 March 2024

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Informed Consent to the present study as documented by a signature
  • Chronic (> 3 years) traumatic or non-traumatic spinal cord injury with a sub-C4-level lesion
  • Wheelchair dependency during activities of daily living
  • vitamin D status <75nmol/L

Who cannot take part

  • Contraindications to the investigational product
  • Visiting a country with increased sun exposure (below the 37th parallel north) within the last month before study enrolment or during the study
  • Clinically relevant disorders,
  • Pressure ulcer grade 3 or 4
  • Pregnancy, breastfeeding
  • Vitamin D supplementation (> 400 IU/day) within the last 12 months
  • Fractures in both arms and/or both legs within the last five years

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main objective of this placebo-controlled randomized double-blinded study is to investigate the effect of vitamin D supplementation on vitamin D status (25(OH)D concentration in the blood) among individuals with a chronic spinal cord injury (SCI). Further, the effects of vitamin D supplementation on several other parameters (e.g. bone density and mood) are investigated, which could reveal positive secondary effects of supplementation that are especially relevant for clinical practice.

The 3 groups in the trial

  • "Low" doseTreatment being tested

    One vial with 600 µg cholecalciferol (corresponding to a total of 24'000 IU vitamin D) and one vial with placebo every month.

    Treatment: Cholecalciferol (Vitamin D3) and Placebo

  • "High" doseTreatment being tested

    Two vials with 600 µg cholecalciferol each (corresponding to a total of 48'000 IU vitamin D) every month.

    Treatment: Cholecalciferol (Vitamin D3)

  • PlaceboPlacebo, for comparison

    Two vials with a placebo every month.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Vitamin D Supplementation in Individuals With a Chronic Spinal Cord Injury - a Placebo-controlled Randomized Double-blinded Study
Publications
Record updated
8 March 2024